liraglutide
NICE recommends Novo’s liraglutide for management of obesity and non-diabetic hyperglycaemia
October 30, 2020Medical Communications, Sales and Marketing NICE, Novo Nordisk, liraglutide
Novo Nordisk’s pre-filled injection Saxenda (liraglutide) has received the backing of drug watchdog NICE, meaning it will now be made …
FDA approves Novo Nordisk’s Victoza for children with type 2 diabetes
June 18, 2019Manufacturing and Production GLP-1, Novo Nordisk, Victoza, diabetes, liraglutide
The FDA has approved Novo Nordisk’s Victoza (liraglutide) for paediatric patients aged 10 years and older with type 2 diabetes. …
Weight loss drug reduces diabetes risk by 80%, according to ICL research
February 27, 2017Research and Development, Sales and Marketing diabetes, icl, liraglutide
Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …
Novo Nordisk presents positive long-term results for Saxenda
June 3, 2016Medical Communications, Research and Development Novo Nordisk, cardiometabolic risk factors, liraglutide, saxenda, weight loss
Novo Nordisk has presented analysis covering three years of a late-stage trial for Saxenda (liarglutide 3mg) , which showed the …
Jardiance scores more cardiovascular outcomes data
November 10, 2015Manufacturing and Production Boehringer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Victoza, cardiovascular outcomes, diabetes, empagliflozin, jardiance, lilly, liraglutide, type 2 diabetes
A sub-group analysis of data from an outcomes study of Boehringer Ingelheim’s and Lilly’s Jardiance has found the diabetes drug …
Novo Nordisk obesity drug is launched in the US
April 23, 2015Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization
Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …
Novo Nordisk obesity drug gets EU approval
March 24, 2015Sales and Marketing EMA, EU, FDA, Victoza, liraglutide, obesity, saxenda
Novo Nordisk’s obesity drug Saxenda has been approved by the European Commission for use across the EU. This approval follows …
Novo Nordisk obesity drug shows added benefits
March 9, 2015Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight
New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …
Novo Nordisk obesity drug gets FDA nod
December 24, 2014Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda
The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …
Novo’s diabetes drug Victoza approved in China
March 16, 2011Sales and Marketing Glucagon-Like Peptide-1, Novo Nordisk, Victoza, diabetes in China, liraglutide, type 2 diabetes
Novo Nordisk’s injectable diabetes drug Victoza has been given regulatory approval in China. The Chinese State Food and Drug Administration …
Diabetes drugs show promise in Alzheimer’s
January 17, 2011Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide
Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
